Lynne Robb is the Vice Chair of LifeArc Board of Trustees and Chair of the Audit and Risk Management Committee. Lynne joined the LifeArc board as a trustee in June 2020, bringing significant experience as a Chief Financial Officer (CFO) in both the charity and life sciences sectors. This includes 11 years as CFO at Cancer Research UK, where she oversaw the merger of the Cancer Research Campaign and the Imperial Cancer Research Fund and was involved in several major developments, including the establishment of the Francis Crick Institute. Lynne is a trustee and vice chair of Prostate Cancer UK, and a non-executive director of the Medicines Discovery Catapult. She is also a director of the Tate and Lyle pension scheme.
Lynne Robb
Latest news
-
LifeArc launches £40m research centres that will unlock new tests, treatments and cures for people living with rare diseases
Read more: LifeArc launches £40m research centres that will unlock new tests, treatments and cures for people living with rare diseases -
First-of-a-kind plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases
Read more: First-of-a-kind plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases -
New £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya
Read more: New £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya